Código QR (código de barras bidimensional)

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

<p>Abstract</p> <p>Background</p> <p>The significance of combination of docetaxel (DTX) with estramustine phosphate (EMP) in castration-resistant prostate cancer (CRPC) patients remains unclear. In this study, we aimed to retrospectively evaluate the efficacy and toxicity of DTX with or without EMP...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Principais autores: Nakano Kazuhiko, Ohta Shigeyuki, Komatsu Kenji, Kubo Taro, Nukui Akinori, Suzuki Kazumi, Kurokawa Shinsuke, Kobayashi Minoru, Morita Tatsuo
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2012-02-01
Serier:BMC Urology
Online adgang:http://www.biomedcentral.com/1471-2490/12/3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!